Suvretta Capital Management 13F holdings, Q2 2022
Holdings as of June 30, 2022 · filings on SEC EDGAR · latest filing →
Suvretta Capital Management disclosed 89 US equity positions worth $2.6bn in its Q2 2022 13F filing. The largest position was RPRX at 4.9% of the reported book, followed by UNH and UNP. Against the Q1 2022 filing, it opened 12 new positions, added to 19 and reduced 15 among the top 50 holdings.
What did Suvretta Capital Management own in Q2 2022? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2022 |
|---|---|---|---|---|---|---|---|
| 1 | RPRX ROYALTY PHARMA PLC | Healthcare | 4.9% | $129.4m | 3,078,506 | 52% | added |
| 2 | UNH UNITEDHEALTH GROUP INC | Healthcare | 4.7% | $123.8m | 240,997 | 0% | held |
| 3 | UNP UNION PAC CORP | Industrials | 4.3% | $113.5m | 532,015 | -13% | reduced |
| 4 | LVS LAS VEGAS SANDS CORP | Consumer Cyclical | 3.7% | $97.5m | 2,903,711 | 28% | added |
| 5 | HUM HUMANA INC | Healthcare | 3.5% | $92.5m | 197,668 | 5% | added |
| 6 | OTIS OTIS WORLDWIDE CORP | Industrials | 3.5% | $91.7m | 1,297,480 | 0% | held |
| 7 | IQV IQVIA HLDGS INC | Healthcare | 3.2% | $85.1m | 392,045 | 1% | added |
| 8 | INTRA-CELLULAR THERAPIES INC | 2.9% | $76.4m | 1,338,700 | -13% | reduced | |
| 9 | EL LAUDER ESTEE COS INC | Consumer Defensive | 2.8% | $74.6m | 292,979 | -21% | reduced |
| 10 | KURA KURA ONCOLOGY INC | Healthcare | 2.8% | $73.6m | 4,017,000 | 3% | added |
| 11 | TPR TAPESTRY INC | Consumer Cyclical | 2.6% | $68.6m | 2,247,709 | -3% | reduced |
| 12 | CNC CENTENE CORP DEL | Healthcare | 2.6% | $68.3m | 807,438 | -33% | reduced |
| 13 | MA MASTERCARD INCORPORATED | Financial Services | 2.5% | $66.0m | 209,111 | 10% | added |
| 14 | TMO THERMO FISHER SCIENTIFIC INC | Healthcare | 2.5% | $65.9m | 121,375 | 5% | added |
| 15 | MSFT MICROSOFT CORP | Technology | 2.4% | $64.2m | 250,157 | -58% | reduced |
| 16 | V VISA INC | Financial Services | 2.4% | $64.0m | 324,818 | -26% | reduced |
| 17 | MIRATI THERAPEUTICS INC | 2.4% | $63.9m | 951,986 | 87% | added | |
| 18 | DHR DANAHER CORPORATION | Healthcare | 2.1% | $55.3m | 218,222 | -6% | reduced |
| 19 | AGIO AGIOS PHARMACEUTICALS INC | Healthcare | 2.0% | $51.5m | 2,321,800 | 97% | added |
| 20 | ARCELLX INC | 1.7% | $44.7m | 2,470,559 | 61% | added | |
| 21 | COR AMERISOURCEBERGEN CORP | Healthcare | 1.7% | $44.5m | 314,691 | -18% | reduced |
| 22 | CANADIAN PAC RY LTD | 1.7% | $44.3m | 634,056 | – | new | |
| 23 | XYZ BLOCK INC | Technology | 1.6% | $41.8m | 679,676 | – | new |
| 24 | INSM INSMED INC | Healthcare | 1.6% | $41.0m | 2,078,680 | 58% | added |
| 25 | VTRS VIATRIS INC | Healthcare | 1.5% | $40.6m | 3,881,900 | – | new |
| 26 | FIS FIDELITY NATL INFORMATION SV | Technology | 1.5% | $40.6m | 443,240 | – | new |
| 27 | HLT HILTON WORLDWIDE HLDGS INC | Consumer Cyclical | 1.5% | $40.2m | 360,491 | -1% | reduced |
| 28 | MAR MARRIOTT INTL INC NEW | Consumer Cyclical | 1.5% | $39.8m | 292,687 | -5% | reduced |
| 29 | HORIZON THERAPEUTICS PUB L | 1.5% | $38.8m | 486,661 | – | new | |
| 30 | KEZAR LIFE SCIENCES INC | 1.4% | $36.5m | 4,412,300 | 213% | added | |
| 31 | MCK MCKESSON CORP | Healthcare | 1.3% | $34.2m | 104,802 | 7% | added |
| 32 | DIS DISNEY WALT CO | Communication Services | 1.3% | $33.1m | 350,926 | – | new |
| 33 | GPN GLOBAL PMTS INC | Industrials | 1.2% | $31.8m | 287,222 | – | new |
| 34 | 290A CHINOOK THERAPEUTICS INC | 1.2% | $31.2m | 1,784,200 | 24% | added | |
| 35 | RH RH | Consumer Cyclical | 1.1% | $28.3m | 133,325 | -27% | reduced |
| 36 | MQ MARQETA INC | Technology | 1.1% | $28.1m | 3,463,704 | -14% | reduced |
| 37 | EXMOC EXXON MOBIL CORP | 0.9% | $24.9m | 290,732 | – | new | |
| 38 | STRO SUTRO BIOPHARMA INC | Healthcare | 0.9% | $24.2m | 4,645,000 | 24% | added |
| 39 | EYPT EYEPOINT PHARMACEUTICALS INC | Healthcare | 0.9% | $23.4m | 2,968,207 | 2% | added |
| 40 | GFL GFL ENVIRONMENTAL INC | Industrials | 0.9% | $23.3m | 903,132 | -60% | reduced |
| 41 | MNST MONSTER BEVERAGE CORP NEW | Consumer Defensive | 0.9% | $23.2m | 249,802 | – | new |
| 42 | CRINETICS PHARMACEUTICALS IN | 0.8% | $21.0m | 1,125,112 | – | new | |
| 43 | RARE ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 0.8% | $20.8m | 348,519 | -34% | reduced |
| 44 | POINT BIOPHARMA GLOBAL INC | 0.8% | $20.5m | 3,014,408 | 0% | held | |
| 45 | MTCH MATCH GROUP INC NEW | Communication Services | 0.8% | $20.1m | 287,786 | – | new |
| 46 | 4XC1 KALVISTA PHARMACEUTICALS INC | 0.7% | $19.0m | 1,928,200 | 10% | added | |
| 47 | PHVS PHARVARIS N V | 0.7% | $18.3m | 827,540 | 0% | held | |
| 48 | MARINUS PHARMACEUTICALS INC | 0.6% | $17.0m | 3,510,831 | 27% | added | |
| 49 | FULC FULCRUM THERAPEUTICS INC | Healthcare | 0.6% | $16.4m | 3,355,624 | 28% | added |
| 50 | NOW SERVICENOW INC | Technology | 0.5% | $12.1m | 25,521 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.